ALXN
Vanguard Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-20,367,300
| Closed | -$3.74B | – | 4587 |
|
|
2021
Q2 | $3.74B | Buy |
20,367,300
+798,317
| +4% | +$147M | 0.09% | 207 |
|
|
2021
Q1 | $2.99B | Buy |
19,568,983
+162,215
| +0.8% | +$24.8M | 0.08% | 254 |
|
|
2020
Q4 | $3.03B | Sell |
19,406,768
-437,152
| -2% | -$68.3M | 0.09% | 225 |
|
|
2020
Q3 | $2.27B | Buy |
19,843,920
+2,831,898
| +17% | +$324M | 0.08% | 266 |
|
|
2020
Q2 | $1.91B | Sell |
17,012,022
-166,689
| -1% | -$18.7M | 0.07% | 308 |
|
|
2020
Q1 | $1.54B | Buy |
17,178,711
+414,294
| +2% | +$37.2M | 0.07% | 304 |
|
|
2019
Q4 | $1.81B | Sell |
16,764,417
-84,772
| -0.5% | -$9.17M | 0.06% | 346 |
|
|
2019
Q3 | $1.65B | Buy |
16,849,189
+200,063
| +1% | +$19.6M | 0.06% | 352 |
|
|
2019
Q2 | $2.18B | Buy |
16,649,126
+211,960
| +1% | +$27.8M | 0.08% | 262 |
|
|
2019
Q1 | $2.22B | Buy |
16,437,166
+215,255
| +1% | +$29.1M | 0.09% | 234 |
|
|
2018
Q4 | $1.58B | Buy |
16,221,911
+410,620
| +3% | +$40M | 0.07% | 300 |
|
|
2018
Q3 | $2.2B | Buy |
15,811,291
+192,857
| +1% | +$26.8M | 0.09% | 231 |
|
|
2018
Q2 | $1.94B | Buy |
15,618,434
+246,793
| +2% | +$30.6M | 0.08% | 250 |
|
|
2018
Q1 | $1.71B | Buy |
15,371,641
+168,887
| +1% | +$18.8M | 0.07% | 288 |
|
|
2017
Q4 | $1.82B | Buy |
15,202,754
+161,204
| +1% | +$19.3M | 0.08% | 268 |
|
|
2017
Q3 | $2.11B | Buy |
15,041,550
+255,719
| +2% | +$35.9M | 0.1% | 206 |
|
|
2017
Q2 | $1.8B | Buy |
14,785,831
+318,375
| +2% | +$38.7M | 0.09% | 245 |
|
|
2017
Q1 | $1.75B | Buy |
14,467,456
+433,293
| +3% | +$52.5M | 0.09% | 234 |
|
|
2016
Q4 | $1.72B | Buy |
14,034,163
+297,620
| +2% | +$36.4M | 0.1% | 221 |
|
|
2016
Q3 | $1.68B | Buy |
13,736,543
+257,825
| +2% | +$31.6M | 0.1% | 212 |
|
|
2016
Q2 | $1.57B | Buy |
13,478,718
+216,269
| +2% | +$25.3M | 0.1% | 221 |
|
|
2016
Q1 | $1.85B | Buy |
13,262,449
+288,491
| +2% | +$40.2M | 0.12% | 164 |
|
|
2015
Q4 | $2.47B | Buy |
12,973,958
+252,272
| +2% | +$48.1M | 0.17% | 115 |
|
|
2015
Q3 | $1.99B | Sell |
12,721,686
-333,010
| -3% | -$52.1M | 0.14% | 133 |
|
|
2015
Q2 | $2.36B | Buy |
13,054,696
+1,783,179
| +16% | +$322M | 0.16% | 120 |
|
|
2015
Q1 | $1.95B | Buy |
11,271,517
+611,169
| +6% | +$106M | 0.13% | 148 |
|
|
2014
Q4 | $1.97B | Buy |
10,660,348
+382,895
| +4% | +$70.8M | 0.14% | 137 |
|
|
2014
Q3 | $1.7B | Buy |
10,277,453
+191,822
| +2% | +$31.8M | 0.13% | 145 |
|
|
2014
Q2 | $1.58B | Buy |
10,085,631
+189,431
| +2% | +$29.6M | 0.12% | 162 |
|
|
2014
Q1 | $1.51B | Buy |
9,896,200
+391,653
| +4% | +$59.6M | 0.13% | 154 |
|
|
2013
Q4 | $1.26B | Buy |
9,504,547
+190,857
| +2% | +$25.4M | 0.11% | 176 |
|
|
2013
Q3 | $1.08B | Buy |
9,313,690
+184,657
| +2% | +$21.4M | 0.11% | 188 |
|
|
2013
Q2 | $842M | Buy |
+9,129,033
| New | +$842M | 0.09% | 233 |
|